Módszerek összehasonlítása

	Bayesian Metabolomics Analysis	Bayesian génkészlet-gazdagodáselemzés (Bayesian GSEA)
Tudományterület	Bioinformatika	Bioinformatika
Módszercsalád	Process / pipeline	Process / pipeline
Keletkezés éve	2005–2010	2004–2007
Megalkotó	Simon Rogers, Mark Girolami and colleagues (Bayesian NMR metabolomics framework, ~2009); broader Bayesian metabolomics developed through 2000s–2010s	Michael A. Newton, Frank A. Quintana and colleagues; building on Subramanian et al. GSEA framework
Típus	Probabilistic statistical pipeline	Probabilistic gene set enrichment method
Alapmű	Rogers, S., Scheltema, R. A., & Girolami, M. A. (2009). Bayesian analysis of metabolomic NMR data. Bioinformatics, 25(14), 1809-1815.	Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., ... & Mesirov, J. P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545-15550.
Alternatív nevek	Bayesian metabolomics, probabilistic metabolomics, Bayesian metabolite profiling, Bayesian metabolic flux analysis	Bayesian GSEA, BGSEA, Bayesian pathway scoring, probabilistic gene set testing
Kapcsolódó	6	6
Összefoglaló	Bayesian metabolomics analysis applies probabilistic inference to metabolite abundance data — typically from mass spectrometry or NMR spectroscopy — to identify differentially abundant metabolites, annotate spectral features, and integrate pathway knowledge. By encoding prior biological knowledge into prior distributions and propagating uncertainty throughout the analysis, it yields more calibrated probability statements about metabolic differences than classical frequentist testing alone.	Bayesian gene set enrichment analysis (Bayesian GSEA) applies a probabilistic framework to determine whether predefined sets of genes — representing biological pathways, cellular processes, or functional categories — are collectively more differentially expressed than expected by chance. Unlike classical frequentist GSEA, the Bayesian approach models uncertainty in expression estimates explicitly, incorporates prior biological knowledge, and produces posterior probabilities of enrichment rather than raw p-values, enabling more principled inference especially in small-sample settings.